M&A activity in the healthcare industry rose to its peak volume in 2015. Although aggregate activity has declined since, historically robust deal value suggests that healthcare M&A is still going strong and entering its final stages. Further supporting this trend, 20% of Apex Leaders business has been comprised of healthcare focused diligence projects. For the last five years, we’ve witnessed notable investments and successful divestitures, begging questions:
- How long will the healthcare industry continue to be a strong investment source?
- How do you know when a subsector is played out?
- Is it too late to enter the market?
- What should investors be mindful of when investigating in a new sector?
In this webinar, top industry experts who have advised on opportunities in the dermatology space will explore the lessons learned in a competitive subsector, and how they can lead sound investment strategy in the broader healthcare industry and beyond.
Attendees will have the opportunity to ask questions during the webinar.